IP Library Granted Patent US 11,072,812
Granted Patent B2
US 11,072,812 · App. 14/207,993 · Granted Jul 27, 2021

Substrates for covalent tethering of proteins to functional groups or solid surfaces

Inventors: Carolyn W. Hitko (Grover Beach, CA); Thomas Kirkland (Atascadero, CA); Poncho Meisenheimer (San Luis Obispo, CA); Rachel Friedman Ohana (Madison, WI); Harry Tetsuo Uyeda (Los Osos, CA); Ji Zhu (Croton On Hudson, NY)
Assignee: PROMEGA CORPORATION
C12Q1/34C12N9/14G01N33/54353
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,072,812
App. No.
14/207,993
Granted
Jul 27, 2021
Kind
B2
Abstract

The present invention provides haloalkane substrates, and linkers for connecting such substrates to functional elements (e.g., tags, labels, surfaces, etc.). Substrates and linkers described herein find use, for example, in labeling, detection, and immobilization of proteins, cells, and molecules. In particular, the linkers provided herein find use within substrates for dehalogenase variants that form covalent bonds with their haloalkane substrates.

Claims (22)

1. A composition comprising a protein linked to a functional group by a linker comprising L1-M-L2-A;

wherein the functional group is not a solid support or 1, 4, 7-triazacyclononane-N, N′, N″-triacetic acid (NOTA);

wherein M is a first carbamate group;

wherein A is (CH 2 ) 6 ;

wherein L1 is a first linker portion that comprises a second carbamate group; wherein the second carbamate group is separated from the functional group by 2 or more linearly connected atoms; wherein the second carbamate group is separated from M by 2 or more linearly connected atoms

wherein L2 is a second linker portion;

wherein L2-A separates M from the protein by 8-16 linearly connected atoms.

2. The composition of claim 1 , wherein said protein comprises a mutant dehalogenase.

3. The composition of claim 1 , wherein said protein is part of a fusion protein.

4. The composition of claim 1 , wherein L2-A separates M from the protein by 12 linearly connected atoms.

5. The composition of claim 1 , wherein the functional group comprises an affinity tag or fluorophore.

6. The composition of claim 1 , wherein the functional group is a biomolecule or small molecule.

7. The composition of claim 1 , wherein L2 does not comprise a carbamate groups.

8. The composition of claim 1 , wherein L2 comprises linearly connected CH 2 and O groups.

9. The composition of claim 8 , wherein L2 consists of linearly connected CH 2 and O groups.

10. The composition of claim 8 , wherein L2 comprises ((CH 2 ) 2 O) x , wherein x=0-5.

11. The composition of claim 10 , wherein L2 comprises ((CH 2 ) 2 O) 2 .

12. The composition of claim 1 , wherein L1 comprises linearly connected CH 2 and O groups.

13. The composition of claim 1 , wherein L1 comprises NHCOO—((CH 2 ) 2 O) 3 , wherein L2 comprises ((CH 2 ) 2 O) 2 , and wherein A is (CH 2 ) 6 .

14. The composition of claim 13 , wherein the functional group comprises an affinity tag, fluorophore, or solid surface.

15. The composition of claim 1 , wherein the functional group is not a chelating agent.

16. A method for preparing a composition of claim 1 wherein the protein is a mutant dehalogenase, comprising contacting (i) a compound of formula R-L1-M-L2-A-X, wherein R is a functional group selected from an affinity tag, a fluorophore, a chromophore, a cross-linking group, an amino acid, a peptide, a polypeptide, a nucleotide, and a lipid; wherein R is not 1, 4, 7-triazacyclononane-N, N′, N″-triacetic acid (NOTA),wherein M is a first carbamate group, wherein L1 is a first linker portion that comprises a second carbamate group; wherein the second carbamate group is separated from R by 2 or more linearly connected atoms; wherein the second carbamate group is separated from M by 2 or more linearly connected atoms; wherein L2 is a second linker portion, wherein A is (CH 2 ) 6 , wherein X is a halogen, and wherein L2-A separates M and X by 6-18 linearly connected atoms with (ii) a mutant dehalogenase that forms covalent bonds with its substrate.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2014
From: HITKO, CAROLYN W.; KIRKLAND, THOMAS; LEVIN, SERGIY; MEISENHEIMER, PONCHO; OHANA, RACHEL FRIEDMAN; UYEDA, HARRY TETSUO; ZHU, JI
To: PROMEGA CORPORATION
Reel/Frame 033229/0075 →